1. Home
  2. DNTH vs ECX Comparison

DNTH vs ECX Comparison

Compare DNTH & ECX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNTH
  • ECX
  • Stock Information
  • Founded
  • DNTH 2015
  • ECX 2017
  • Country
  • DNTH United States
  • ECX China
  • Employees
  • DNTH N/A
  • ECX N/A
  • Industry
  • DNTH Biotechnology: Pharmaceutical Preparations
  • ECX EDP Services
  • Sector
  • DNTH Health Care
  • ECX Technology
  • Exchange
  • DNTH Nasdaq
  • ECX Nasdaq
  • Market Cap
  • DNTH 670.7M
  • ECX 584.9M
  • IPO Year
  • DNTH N/A
  • ECX N/A
  • Fundamental
  • Price
  • DNTH $22.29
  • ECX $1.68
  • Analyst Decision
  • DNTH Strong Buy
  • ECX
  • Analyst Count
  • DNTH 9
  • ECX 0
  • Target Price
  • DNTH $46.43
  • ECX N/A
  • AVG Volume (30 Days)
  • DNTH 245.5K
  • ECX 1.0M
  • Earning Date
  • DNTH 03-20-2025
  • ECX 02-26-2025
  • Dividend Yield
  • DNTH N/A
  • ECX N/A
  • EPS Growth
  • DNTH N/A
  • ECX N/A
  • EPS
  • DNTH N/A
  • ECX N/A
  • Revenue
  • DNTH $5,366,000.00
  • ECX $778,608,168.00
  • Revenue This Year
  • DNTH $100.14
  • ECX $20.12
  • Revenue Next Year
  • DNTH N/A
  • ECX $32.70
  • P/E Ratio
  • DNTH N/A
  • ECX N/A
  • Revenue Growth
  • DNTH 51.41
  • ECX 25.45
  • 52 Week Low
  • DNTH $18.35
  • ECX $0.96
  • 52 Week High
  • DNTH $33.77
  • ECX $3.09
  • Technical
  • Relative Strength Index (RSI)
  • DNTH 49.77
  • ECX 35.40
  • Support Level
  • DNTH $21.28
  • ECX $1.59
  • Resistance Level
  • DNTH $23.28
  • ECX $1.79
  • Average True Range (ATR)
  • DNTH 1.75
  • ECX 0.13
  • MACD
  • DNTH 0.17
  • ECX -0.04
  • Stochastic Oscillator
  • DNTH 79.92
  • ECX 3.44

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

About ECX ECARX Holdings Inc. Ordinary shares

ECARX Holdings Inc is engaged in the sales of system-on-chip core modules, automotive computing platform products, and software stacks as well as the provision of research and development services primarily in the People's Republic of China. The company's core products include infotainment head units, digital cockpits, vehicle chip-set solutions, a core operating system, and an integrated software stack. Beyond this, ECARX is developing a full-stack automotive computing platform. It is engaged in automotive intelligence and networking.

Share on Social Networks: